东阳光：控股股东之一致行动人宜昌药业股份质押2000万股

Group 1 - Company Dongyangguang announced that its shareholder Yichang Pharmaceutical has pledged 20 million shares, with a total of approximately 51 million shares pledged, accounting for 93.51% of its holdings [1] - The controlling shareholder Shenzhen Dongyangguang Industrial Development has pledged approximately 542 million shares, representing 87.37% of its holdings, while the total pledged shares by the controlling shareholder and its concerted parties amount to approximately 1.232 billion shares, or 77.49% of their combined holdings [1] - As of the first half of 2025, Dongyangguang's revenue composition includes: high-end aluminum foil at 40.81%, new chemical materials at 27.63%, electronic components at 25.4%, other businesses at 2.63%, and energy materials at 2.61% [1] Group 2 - The market capitalization of Dongyangguang is reported to be 63 billion yuan [2]